130 related articles for article (PubMed ID: 1888631)
1. The effect of preincubation with cimetidine on the N-hydroxylation of dapsone by human liver microsomes.
Tingle MD; Coleman MD; Park BK
Br J Clin Pharmacol; 1991 Jul; 32(1):120-3. PubMed ID: 1888631
[TBL] [Abstract][Full Text] [Related]
2. An investigation of the role of metabolism in dapsone-induced methaemoglobinaemia using a two compartment in vitro test system.
Tingle MD; Coleman MD; Park BK
Br J Clin Pharmacol; 1990 Dec; 30(6):829-38. PubMed ID: 2288829
[TBL] [Abstract][Full Text] [Related]
3. Evidence that the biotransformation of dapsone and monoacetyldapsone to their respective hydroxylamine metabolites in rat liver microsomes is mediated by cytochrome P450 2C6/2C11 and 3A1.
Vage C; Svensson CK
Drug Metab Dispos; 1994; 22(4):572-7. PubMed ID: 7956732
[TBL] [Abstract][Full Text] [Related]
4. The use of a three compartment in vitro model to investigate the role of hepatic drug metabolism in drug-induced blood dyscrasias.
Tingle MD; Park BK
Br J Clin Pharmacol; 1993 Jul; 36(1):31-8. PubMed ID: 8373710
[TBL] [Abstract][Full Text] [Related]
5. Bioactivation of dapsone to a cytotoxic metabolite: in vitro use of a novel two compartment system which contains human tissues.
Riley RJ; Roberts P; Coleman MD; Kitteringham NR; Park BK
Br J Clin Pharmacol; 1990 Sep; 30(3):417-26. PubMed ID: 2223420
[TBL] [Abstract][Full Text] [Related]
6. The use of cimetidine as a selective inhibitor of dapsone N-hydroxylation in man.
Coleman MD; Scott AK; Breckenridge AM; Park BK
Br J Clin Pharmacol; 1990 Nov; 30(5):761-7. PubMed ID: 2271376
[TBL] [Abstract][Full Text] [Related]
7. Reduction of dapsone hydroxylamine to dapsone during methaemoglobin formation in human erythrocytes in vitro--II. Movement of dapsone across a semipermeable membrane into erythrocytes and plasma.
Coleman MD; Jacobus DP
Biochem Pharmacol; 1993 Oct; 46(8):1363-8. PubMed ID: 8240384
[TBL] [Abstract][Full Text] [Related]
8. Gonadal influence on the metabolism and haematological toxicity of dapsone in the rat.
Coleman MD; Tingle MD; Winn MJ; Park BK
J Pharm Pharmacol; 1990 Oct; 42(10):698-703. PubMed ID: 1982141
[TBL] [Abstract][Full Text] [Related]
9. Monoacetyldapsone inhibition of dapsone N-hydroxylation by human and rat liver microsomes.
Irshaid Y; Adedoyin A; Lotze M; Branch RA
Drug Metab Dispos; 1994; 22(1):161-4. PubMed ID: 8149877
[TBL] [Abstract][Full Text] [Related]
10. Metabolism of dapsone to its hydroxylamine by CYP2E1 in vitro and in vivo.
Mitra AK; Thummel KE; Kalhorn TF; Kharasch ED; Unadkat JD; Slattery JT
Clin Pharmacol Ther; 1995 Nov; 58(5):556-66. PubMed ID: 7586950
[TBL] [Abstract][Full Text] [Related]
11. Studies on the toxicity of analogues of dapsone in-vitro using rat, human and heterologously expressed metabolizing systems.
Coleman MD; Smith SN; Kelly DE; Kelly SL; Seydel JK
J Pharm Pharmacol; 1996 Sep; 48(9):945-50. PubMed ID: 8910859
[TBL] [Abstract][Full Text] [Related]
12. Reduction of dapsone hydroxylamine to dapsone during methaemoglobin formation in human erythrocytes in vitro.
Coleman MD; Jacobus DP
Biochem Pharmacol; 1993 Mar; 45(5):1027-33. PubMed ID: 8461032
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of dapsone-induced methaemoglobinaemia by cimetidine in the rat during chronic dapsone administration.
Coleman MD; Tingle MD; Park BK
J Pharm Pharmacol; 1991 Mar; 43(3):186-90. PubMed ID: 1675276
[TBL] [Abstract][Full Text] [Related]
14. N-hydroxylation of 4,4'-diaminodiphenylsulphone (Dapsone) by liver microsomes, and in dogs and humans.
Uehleke H; Tabarelli S
Naunyn Schmiedebergs Arch Pharmacol; 1973; 278(1):55-68. PubMed ID: 4145470
[No Abstract] [Full Text] [Related]
15. An investigation into the haematological toxicity of structural analogues of dapsone in-vivo and in-vitro.
Coleman MD; Tingle MD; Hussain F; Storr RC; Park BK
J Pharm Pharmacol; 1991 Nov; 43(11):779-84. PubMed ID: 1686906
[TBL] [Abstract][Full Text] [Related]
16. Structural basis for the haemotoxicity of dapsone: the importance of the sulphonyl group.
Mahmud R; Tingle MD; Maggs JL; Cronin MT; Dearden JC; Park BK
Toxicology; 1997 Feb; 117(1):1-11. PubMed ID: 9020194
[TBL] [Abstract][Full Text] [Related]
17. Selective inhibition of rat hepatic microsomal cytochrome P-450. II. Effect of the in vitro administration of cimetidine.
Chang T; Levine M; Bellward GD
J Pharmacol Exp Ther; 1992 Mar; 260(3):1450-5. PubMed ID: 1545404
[TBL] [Abstract][Full Text] [Related]
18. Reduction of dapsone hydroxylamine to dapsone during methaemoglobin formation in human erythrocytes in vitro. IV: Implications for the development of agranulocytosis.
Coleman MD; Simpson J; Jacobus DP
Biochem Pharmacol; 1994 Oct; 48(7):1349-54. PubMed ID: 7945432
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of dapsone-induced methaemoglobinaemia in the rat isolated perfused liver.
Coleman MD; Hoaksey PE; Breckenridge AM; Park BK
J Pharm Pharmacol; 1990 May; 42(5):302-7. PubMed ID: 1976775
[TBL] [Abstract][Full Text] [Related]
20. Bioactivation of dapsone to a cytotoxic metabolite by human hepatic microsomal enzymes.
Coleman MD; Breckenridge AM; Park BK
Br J Clin Pharmacol; 1989 Oct; 28(4):389-95. PubMed ID: 2590600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
